NORTHWEST BIOTHERAPEUTICS INC Accounts Payable and Accrued Liabilities, Current
NORTHWEST BIOTHERAPEUTICS INC (NWBO) had Accounts Payable and Accrued Liabilities, Current of $32.53 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Accounts Payable and Accrued Liabilities, Current $32.53M.
- 2026-03-31: Accounts Payable and Accrued Liabilities, Current $31.58M.
- 2025-12-31: Accounts Payable and Accrued Liabilities, Current $30.82M.
- 2025-09-30: Accounts Payable and Accrued Liabilities, Current $26.88M.
| Period end | Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $32.53M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $31.58M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $30.82M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $26.88M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $23.66M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $20.75M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $16.97M 10-K · filed 2026-04-15 |
| 2024-09-30 | $17.91M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $15.14M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $15.09M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $10.24M 10-K · filed 2025-03-31 |
| 2023-09-30 | $12.33M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $12.11M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $11.89M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $10.69M 10-K · filed 2024-03-05 |
| 2022-09-30 | $8.24M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $8.37M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $7.73M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $6.98M 10-K · filed 2023-02-28 |
| 2021-09-30 | $9.27M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $8.16M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $7.47M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $7.38M 10-K · filed 2022-03-01 |
| 2020-09-30 | $9.17M 10-Q · filed 2021-01-15 |
| 2020-06-30 | $7.77M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $7.17M 10-Q · filed 2020-06-24 |
| 2019-12-31 | $6.35M 10-K · filed 2021-03-31 |
| 2019-09-30 | $6.61M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.89M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $15.32M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $15.51M 10-K · filed 2020-03-16 |
| 2018-09-30 | $21.96M 10-Q · filed 2018-11-16 |
| 2018-06-30 | $18.38M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $12.33M 10-Q · filed 2018-05-16 |
| 2017-12-31 | $13.02M 10-K · filed 2019-04-02 |
| 2017-09-30 | $17.03M 10-Q · filed 2017-11-20 |
| 2017-06-30 | $16.15M 10-Q · filed 2017-08-21 |
| 2016-12-31 | $13.24M 10-K · filed 2018-04-17 |
| 2011-12-31 | $600.00K 10-Q · filed 2012-11-14 |
| 2011-09-30 | $4.60M 10-Q · filed 2012-11-14 |